Trade Mark Journal No.2026/034 21 August 2026
WO0000001914901 (42,44)
Office of origin: United States of America
Date of International Registration:16 March 2026
Date of designation in the UK:
16 March 2026

The mark consists of three concentric arches with the words "CARIS CHROMOSEQ" below the arches. The "A" in "CARIS" is in a stylized format.
- Class 42
- Medical and scientific research in the field of oncology; providing medical and scientific research information in the field of oncology; medical and scientific research, namely, whole genome and whole transcriptome sequencing assays for biomarker detection and analysis in patients with leukemia, lymphoma, myeloma, or other hematologic malignancies.
- Class 44
- Medical testing for diagnostic, prognostic, or treatment purposes; medical testing, namely, providing whole genome and whole transcriptome sequencing assays for biomarker detection in patients with leukemia, lymphoma, myeloma, or other hematologic malignancies.
Caris MPI, Inc.
Representative: Anne Fleeson Womble Bond Dickinson (US) LLP, One West Fourth Street, Winston-Salem NC 27101, UNITED STATES OF AMERICA